Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 17 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00003136Phase 1/2
- S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in RemissionCompletedNCT00003120Phase 3
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian CancerCompletedNCT00003080Phase 1
- Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerCompletedNCT00003072Phase 2
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00003064Phase 1/2
- Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete RemissionCompletedNCT00002977Phase 1
- Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian CancerCompletedNCT00002928Phase 2
- Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian CancerCompletedNCT00002913Phase 1
- Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00002895Phase 3
- Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian CancerCompletedNCT00002894Phase 3
- Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerTerminatedNCT00002819Phase 3
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian CancerCompletedNCT00002734Phase 1
- Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
- Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian CancerCompletedNCT00002671Phase 2
- Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian CancerStatus unknownNCT00002487Phase 2
- Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial CancerStatus unknownNCT00002477Phase 3
- Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian CancerCompletedNCT00002474Phase 2
- A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)CompletedNCT00001938
- A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian CancerCompletedNCT00001426Phase 2